STAT Plus: A closer look at Pete Buttigieg’s aggressive, wonky plan to lower drug prices
The following is an excerpt from STAT’s deep dive report into the Democrats running for president in 2020 and their proposals for pharmaceutical industry reform. Learn more here.
WASHINGTON — Pete Buttigieg has said he wants drug companies to “thrive.”
Continue to STAT Plus to read the full story…
